Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-20 · accession 0001005286-25-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-20 | LFCR | Josephs Paul | CEO, Dir | F - Tax | $6.63 | -21.5K | 538.2K | -4% | -$142.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-20 | F | D | 21,532 | $6.63 | 538,185 | D | — | — | (F1) Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with an RSU vesting. |